A formulation chemist at a personal care manufacturer in the UK recalled the supplier qualification process for their triclosan-alternative antimicrobial program as one of the more technically demanding they had completed. Their target compound was hydroxydichlorodiphenyl ether — specifically the 5-chloro-2-(2,4-dichlorophenoxy)phenol isomer used in antimicrobial formulations — and the challenge was that the compound sits in a regulatory environment that had been shifting for years, with implications for documentation, purity requirements, and application disclosure that changed between the time they started the project and when they finalized their supplier. The chemistry wasn’t the problem. The regulatory paperwork was where the complexity lived.